A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of PHX1149T as Monotherapy in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of PHX1149T as Monotherapy in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of PHX1149T as Monotherapy in Subjects with Type 2 Diabetes Mellitus
Inclusion Criteria:
Exclusion Criteria:
Caba, Buenos Aires, Argentina
Kelantan, Malaysia
Sarawak, Malaysia
Chiclayo-Lambayeque, Chiclayo, Peru
San Isisdro, Lima, Peru
Jud. Brasov, Brașov County, Romania
Ratchatavi, Bangkok, Thailand
Muang, Changwat Khon Kaen, Thailand
2A Postysheva Pr., Kharkov, Ukraine
Kyiv, Kyiv Oblast, Ukraine
Vinnytsa, Vinnytsa, Ukraine